Pharmaceutical Product Development (PPD) announced Colin Hill has been named to the company’s board of directors. Hill is the chairman, chief executive officer and co-founder of GNS Healthcare.
PPD has named Colin Hill to the company’s board of directors. Hill is the chairman, chief executive officer and co-founder of GNS Healthcare.
“Colin Hill is a renowned voice in health care technology and pioneer in precision medicine, and he brings to our company impressive leadership experience in commercializing machine learning technologies in the biopharmaceutical and managed care industries,” said David Simmons, chairman and chief executive officer of PPD. “He is an excellent addition to our board because, like PPD, he has a keen focus on using technological innovations, real-world evidence and patient-centric solutions to improve patient health.”
Hill co-founded GNS Healthcare in 2000 out of Cornell University. The company leverages the latest innovations in machine learning, computing and mathematics to transform biomedical and health care data into solutions and treatments that dramatically reduce the burden of human disease.
“I am honored to join the PPD board and look forward to collaborating with such a leading-edge organization,” Hill said. “PPD’s commitment to transforming the drug development process by leveraging data and innovative technology is resulting in the accelerated launching of new drugs to market, which translates into improved health outcomes for patients.”
In addition to PPD, Hill serves on the board of mobile health information company Biotelemetry. He is also a founding board member of TMed (Transforming Medicine: The Elizabeth Kauffman Institute), a non-profit foundation dedicated to the advancement of personalized medicine. In 2016, he was appointed by Massachusetts Gov. Charlie Baker to the Massachusetts Digital Health Council.
Hill was a founding member of the board of directors of AesRx, a biopharmaceutical company devoted to the development of new treatments for sickle cell disease. He also was the founding chairman of O’Reilly Media’s Strata Rx in 2012, the industry’s first health care big data conference. In 2004, Hill was named to MIT Technology Review’s TR100 list of the top 100 innovators in the world under the age of 35.
Hill earned a bachelor’s degree in physics from Virginia Tech, as well as master’s degrees in physics from both McGill University and Cornell University.